RE:RE:RE:RE:Tracked him downNo need to apologize or explain...just thankful for the contact. And although it disturbs me some that it adds to the uncertainty, there are other plausible explanations...the most plausible being that when AW sourced their CBD supplier, Centuria had their own C10 process which they claimed had the onset\offset characteristics Infuz20 has (see AW web site) ...so it would be a one stop buy for them.
Still not happy because it does beg more questions, but all in all still patient and trusting Moosehead in this. And my ultimate backstop is still SPR itself with flower and extracts and plans for its own line of beverages and edibles...where the beverages will likely be in some category that MH is not going to contest...ie a "non beer"
Hailmerry wrote: I may have misunderstood what he was telling me but we went onto investor communication very quickly and didn't have a chance to Ashe anymore about it and I am. Little ADHD.